aem3-305-testing

Latest Press Releases

• 01 Aug 2024 - Merck Closes Mirus Bio Acquisition, Bolstering Viral Vector Bioprocessing Offering
• 24 Jul 2024 - Merck Signs MoU with Gene Therapy Research Institution to Accelerate Viral Vector-based Gene Therapy for Parkinson’s Disease
• 12 Jul 2024 - Merck Begins Commercial Production of First GMP-Compliant Manufacturing Line for Cell Culture Media in China
• 03 Jul 2024 - Merck Announces Non-Binding MoU with Afrigen Biologics for Development of mRNA Vaccine Technology Platform
• 18 Jun 2024 - Merck and The Michael J. Fox Foundation Offer Service to Advance Parkinson’s research
• More Press Releases